Clinical trials are conducted in multiple phases to evaluate the safety and efficacy of a new cancer treatment in humans. Phase I trials focus on safety and dosage, Phase II trials assess efficacy and side effects, and Phase III trials compare the new treatment to existing standard treatments. Successful completion of these phases is required for regulatory approval by agencies like the FDA or EMA.
